
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply | Pharmaceuticals industry
Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce

Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce

An Amazon worker delivers packages in Los Angeles. Damian Dovarganes/AP hide caption toggle caption